European Medical Technology Leaders Push Regulatory Reform
The potential policy shifts aim to lower compliance burdens for the thousands of small and medium-sized firms operating in Europe.
Updated on Oct. 22, 2026 in Healthcare
Live Poll
Should governments prioritize strict medical device regulations over the speed of bringing new technology to market?
Industry leaders are meeting at the Global Access 2026 conference in Galway to address regulatory reforms for medical technology. The discussions aim to streamline European frameworks that currently impact thousands of small and medium-sized enterprises.
Why it matters
Operators face increased complexity and uncertainty under current regulations, which have contributed to Europe losing market share while the U.S. sector expanded. Reform is now a priority to preserve patient access and maintain industry research output.
Europe’s medical technology sector consists of 38,000 companies, 90% of which are small and medium-sized enterprises. Despite 15,905 patent filings in 2025, the sector now holds 25.6% of the global market share versus 28% a decade ago.
The players
European Commission
The executive branch of the European Union responsible for drafting legislation and enforcing regulatory standards across member states.
European Patent Office
The intergovernmental institution that examines patent applications and grants protection for inventions across Europe.
The details
The current focus is on reforming the EU's Medical Device Regulation and In Vitro Diagnostic Medical Devices Regulation, which industry participants argue have created burdensome operational barriers. Ireland is using its EU Council Presidency to mediate between regulatory bodies and manufacturers to align compliance requirements with rapid technological shifts.
Timeline
2025: 15,905 medtech patent applications were filed with the European Patent Office.
October 21-22, 2026: The Global Access 2026 conference is held at The Galmont Hotel in Galway.
Market Landscape
The push for regulatory change is a direct response to the operational friction caused by the Medical Device Regulation. This development follows a decade where European market share stagnated while U.S.-based competitors captured larger portions of the global medtech sector.
Operators should monitor upcoming shifts in EU regulatory frameworks, as these will define future compliance costs and product registration timelines. Small and medium-sized enterprises in particular should evaluate how proposed reforms to IVD regulations will impact their existing research and development budgets.
The takeaway
The move toward regulatory reform signals a critical effort to reduce the compliance burden for the 38,000 companies operating in Europe. Operators should track legislative updates from the European Commission to identify potential changes to device approval processes before year-end.
Further reading
For broader insights on industry standards, visit the Healthcare section.
Source note: This article includes information reported by Advertiser Newspaper Group.
Live Poll
Should governments prioritize strict medical device regulations over the speed of bringing new technology to market?
